Organic Letters
Letter
135, 8133−8136. (d) Huang, D.; Liu, X.; Li, L.; Cai, Y.; Liu, W.; Shi, Y. J.
Am. Chem. Soc. 2013, 135, 8101−8104. (e) Chen, F.; Tan, C. K.; Yeung,
Y.-Y. J. Am. Chem. Soc. 2013, 135, 1232−1235. (f) Wang, Y.-M.; Wu, J.;
Hoong, C.; Rauniyar, V.; Toste, F. D. J. Am. Chem. Soc. 2012, 134,
12928−12931. (g) Paull, D. H.; Fang, C.; Donald, J. R.; Pansick, A. D.;
Martin, S. F. J. Am. Chem. Soc. 2012, 134, 11128−11131. (h) Ikeuchi, K.;
Ido, S.; Yoshimura, S.; Asakawa, T.; Inai, M.; Hamashima, Y.; Kan, T.
Org. Lett. 2012, 14, 6016−6019. (i) Jiang, X.; Tan, C. K.; Zhou, L.;
Yeung, Y.-Y. Angew. Chem., Int. Ed. 2012, 51, 7771−7775. (j) Denmark,
S. E.; Burk, M. T. Org. Lett. 2012, 14, 256−259. (k) Huang, D.; Wang,
H.; Xue, F.; Guan, H.; Li, L.; Peng, X.; Shi, Y. Org. Lett. 2011, 13, 6350−
6353. (l) Zhou, L.; Chen, J.; Tan, C. K.; Yeung, Y.-Y. J. Am. Chem. Soc.
2011, 133, 9164−9167.
(15) For pioneering contribution, see: (a) Okino, T.; Hoashi, Y.;
Takemoto, Y. J. Am. Chem. Soc. 2003, 125, 12672−12673. For selected
reviews, see: (b) Lu, L.-Q.; An, X.-L.; Chen, J.-R.; Xiao, W.-J. Synlett
2012, 23, 490−508. (c) Siau, W.-Y.; Wang, J. Catal. Sci. Technol. 2011, 1,
1298−1310. (d) Takemoto, Y. Chem. Pharm. Bull. 2010, 58, 593−601.
(16) For a more comprehensive optimization of catalyst structure,
reaction conditions, and other details, see the Supporting Information.
(17) CCDC 1002958 contains the crystallographic data for 3a (also
available as Supporting Information). These data can be obtained free of
charge from the Cambridge Crystallographic Data Centre via www.ccdc.
(7) For selected chlorocyclizations, see: (a) Han, X.; Dong, C.; Zhou,
H.-B. Adv. Synth. Catal. 2014, 356, 1275−1280. (b) Jaganathan, A.;
Staples, R. J.; Borhan, B. J. Am. Chem. Soc. 2013, 135, 14806−14813.
(c) Yin, Q.; You, S.-L. Org. Lett. 2013, 15, 4266−4269. (d) Miles, D. H.;
Veguillas, M.; Toste, F. D. Chem. Sci. 2013, 4, 3427−3431.
(e) Jaganathan, A.; Garzan, A.; Whitehead, D. C.; Staples, R. J.;
Borhan, B. Angew. Chem., Int. Ed. 2011, 50, 2593−2596.
(8) For selected fluorocyclizations, see: (a) Parmar, D.; Maji, M. S.;
Rueping, M. Chem.−Eur. J. 2014, 20, 83−86. (b) Shunatona, H. P.;
Fruh, N.; Wang, Y.-M.; Rauniyar, V.; Toste, F. D. Angew. Chem., Int. Ed.
̈
2013, 52, 7724−7727. (c) Rauniyar, V.; Lackner, A. D.; Hamilton, G. L.;
Toste, F. D. Science 2011, 334, 1681−1684. (d) Lozano, O.; Blessley, G.;
del Campo, T. M.; Thompson, A. L.; Giuffredi, G. T.; Bettati, M.;
Walker, M.; Borman, R.; Gouverneur, V. Angew. Chem., Int. Ed. 2011, 50,
8105−8109.
(9) (a) Zhao, Y.; Jiang, X.; Yeung, Y.-Y. Angew. Chem., Int. Ed. 2013, 52,
8597−8601. (b) Tripathi, C. B.; Mukherjee, S. Angew. Chem., Int. Ed.
2013, 52, 8450−8453.
(10) During preparation of this manuscript, Chen, Xiao, and co-
workers reported a non-enantioselective haloaminocyclization of β,γ-
unsaturated hydrazones: Hu, X.-Q.; Chen, J.-R.; Wei, Q.; Liu, F.-L.;
Deng, Q.-H.; Zou, Y.-Q.; Xiao, W.-J. Eur. J. Org. Chem. 2014, 3082−
3086. For another cyclization of similar substrates, see: Zhu, M.-K.;
Chen, Y.-C.; Loh, T.-P. Chem.−Eur. J. 2013, 19, 5250−5254.
(11) For selected reviews, see: (a) Rahman, M. A.; Siddiqui, A. A. Int. J.
Pharm. Sci. Drug Res. 2010, 2, 165−175. (b) Kumar, S.; Bawa, S.; Drabu,
S.; Kumar, R.; Gupta, H. Recent Pat. Antiinfect. Drug Discovery 2009, 4,
154−163.
(12) (a) Coleman, P. J.; Cox, C. D. Mitotic Kinesin Inhibitors. U.S.
Patent 20090042966 A1, Feb 12, 2009. (b) Roecker, A. J.; Coleman, P.
J.; Mercer, S. P.; Schreier, J. D.; Buser, C. A.; Walsh, E. S.; Hamilton, K.;
Lobell, R. B.; Tao, W.; Diehl, R. E.; South, V. J.; David, J. P.; Kohl, N. E.;
Yan, Y.; Kuo, L. C.; Li, C.; Fernandez-Metzler, C.; Mahan, E. A.;
Prueksaritanont, T.; Hartman, G. D. Bioorg. Med. Chem. Lett. 2007, 17,
5677−5682. (c) Coleman, P. J.; Schreier, J. D.; Cox, C. D.; Fraley, M. E.;
Garbaccio, R. M.; Buser, C. A.; Walsh, E. S.; Hamilton, K.; Lobell, R. B.;
Rickert, K.; Tao, W.; Diehl, R. E.; South, V. J.; David, J. P.; Kohl, N. E.;
Yan, Y.; Kuo, L.; Prueksaritanont, T.; Li, C.; Mahan, E. A.; Fernandez-
Metzler, C.; Salata, J. J.; Hartman, G. D. Bioorg. Med. Chem. Lett. 2007,
17, 5390−5395.
(13) For selected examples, see: (a) Chen, J.-R.; Dong, W.-R.; Candy,
M.; Pan, F.-F.; Jorres, M.; Bolm, C. J. Am. Chem. Soc. 2012, 134, 6924−
̈
6927. (b) Campbell, N. R.; Sun, B.; Singh, R. P.; Deng, L. Adv. Synth.
Catal. 2011, 353, 3123−3128. (c) Mahe,
́
O.; Dez, I.; Levacher, V.;
Briere, J.-F. Angew. Chem., Int. Ed. 2010, 49, 7072−7075. (d) Muller, S.;
̀
̈
List, B. Angew. Chem., Int. Ed. 2009, 48, 9975−9978. (e) Sibi, M. P.;
Stanley, L. M.; Jasperse, C. P. J. Am. Chem. Soc. 2005, 127, 8276−8277.
(f) Kanemasa, S.; Kanai, T. J. Am. Chem. Soc. 2000, 122, 10710−10711.
For reviews, see: (g) Kuchenthal, C.-H.; Maison, W. Synthesis 2010,
̈
́
719−740. (h) Leavai, A. J. Heterocycl. Chem. 2002, 39, 1−13.
(14) For selected examples, see: (a) Gao, L.; Hwang, G.-S.; Lee, M. Y.;
Ryu, D. H. Chem. Commun. 2009, 5460−5462. (b) Sibi, M. P.; Stanley,
L. M.; Soeta, T. Org. Lett. 2007, 9, 1553−1556. (c) Kano, T.;
Hashimoto, T.; Maruoka, K. J. Am. Chem. Soc. 2006, 128, 2174−2175.
(d) Sibi, M. P.; Stanley, L. M.; Soeta, T. Adv. Synth. Catal. 2006, 348,
2371−2375.
D
dx.doi.org/10.1021/ol5013982 | Org. Lett. XXXX, XXX, XXX−XXX